
BAM15 is a molecule that has been identified as a potential drug for the treatment of obesity. It works by increasing the activity of mitochondria, which are the energy-producing organelles in cells, leading to an increased energy expenditure from the consumed food.
BAM 15 is able to increase O2 consumption across a broad dosing range without increasing ROS. BAM 15 and FCCP are structurally unrelated and it is observed that low doses of BAM 15 from 100 nM to 1 μM increase cellular O2 consumption rate (OCR) to a similar degree as FCCP, but higher concentrations from 1 μM to 50 μM reveal that BAM 15 is able to maintain uncoupled respiration at a high rate in a range of cell lines. BAM 15 is fully capable of increasing mitochondrial respiration in the presence of oligomycin and does so across a broader concentration range than FCCP in both myoblasts and hepatocytes. BAM 15 induces mitochondrial swelling, demonstrating that BAM 15 is a protonophore. BAM15-treated cells are more viable than FCCP-treated cells when administered across a broad dosing range up to 50 μM.
Product name | BAM15 |
CAS number | 210302-17-3 |
Molecular formula | C16H10F2N6O |
Molecular weight | 340.29 |
Purity | ≥99% |
Appearance | yellow Powder |
Grade | Medical Grade |
MOQ | 1 g |




